Subscribe to Updates
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated!
Browsing: Heart Disease
This is the shocking moment a high-stakes casino player suffered a massive heart attack just after winning a £3.2 million…
Atherosclerotic plaque affects 42% of adults without heart disease. Researchers from the University of Bristol have uncovered a new disease-causing…
MONDAY, June 24, 2024 (HealthDay News) — Automated quantitative testing of NT-proBNP and interleukin-1 receptor-like 1 (IL-1 RL1) can identify…
On June 13, 2024, Heart South Cardiovascular Group (“Heart South”) filed a data breach notification with the U.S. Department of…
Using animals to study heart disease does not necessarily translate into positive outcomes for human health, and the human heart…
Originally developed to treat type 2 diabetes and obesity, semaglutide significantly improves symptoms in men and women with common heart…
clock: New report looks at gender disparities and heart disease A soon-to-be-released report from the American Heart Association estimates that…
Alnylam Pharmaceuticals announced clinical trial results on Monday that represent the best-case scenario for the company’s stock and are likely…
34 minutes agoTop Fed Official Doesn’t Expect Lower Interest Rates This Year”,”scope”:{“topStory”:{“index”:1,”title”:”Top Fed Official Doesn’t Expect Lower Interest Rates This…
Alnylam reported a successful Phase 3 trial of its heart drug butrisiran, also known as Ambutra. Source: Pavel Kapiš /…